Ultragenyx Pharmaceutical (RARE)
NASDAQ:RARE
Holding RARE?
Track your performance easily

Ultragenyx Pharmaceutical (RARE) Balance Sheet

744 Followers

Ultragenyx Pharmaceutical Balance Sheet

Ultragenyx Pharmaceutical's total assets for Q3 2024 were $1.54B, a decrease of -4.95% from the previous quarter. RARE total liabilities were $1.18B for the fiscal quarter, a -0.13% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 1.49B$ 1.55B$ 1.52B$ 1.76B$ 1.14B
Total Liabilities
$ 1.22B$ 1.19B$ 599.84M$ 605.18M$ 481.73M
Total Equity Gross Minority
$ 275.41M$ 352.49M$ 922.56M$ 1.15B$ 653.76M
Total Capitalization
$ 275.41M$ 352.49M$ 922.56M$ 1.15B$ 653.76M
Preferred Stock Equity
-----
Capital Lease Obligations
---$ 48.23M$ 36.99M
Currency in USD

Ultragenyx Pharmaceutical Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis